Evidence map›Paper›PMID 41257188›Full record

ReviewERJ open research2025

Managing breathlessness for people with advanced respiratory disease.

Amy Pascoe, Harrison Birch, Natasha Smallwood

Abstract readReview
In one paragraph

Review in ERJ open research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Trial
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Amy PascoeDepartment of Respiratory Research at Alfred Health, School of Translational Medicine, Monash University, Melbourne, VIC, Australia.ORCID https://orcid.org/0000-0002-3555-6856
Harrison BirchMelbourne Medical School, University of Melbourne, Melbourne, VIC, Australia.
Natasha SmallwoodDepartment of Respiratory Research at Alfred Health, School of Translational Medicine, Monash University, Melbourne, VIC, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic respiratory diseases encompass diverse, nonmalignant respiratory diseases that share common symptoms, including cough, fatigue and chronic breathlessness. Chronic breathlessness imposes a significant burden on patients and is challenging for clinicians to manage effectively. Effective management of breathlessness requires a stepwise approach that involves 1) recognition and measurement of the symptom; 2) identification and optimal disease-directed management of any underlying conditions; and 3) consideration and trial of nonpharmacological management approaches. Currently, there is a dearth of safe and effective pharmacological approaches. Models of care for managing breathlessness vary broadly. While integrated specialist respiratory services are effective at improving breathlessness management, they are limited in capacity. Upskilling primary and community care can expand the reach and accessibility of breathlessness management. Ultimately, fostering self-management skills to empower people with breathlessness to better control their daily symptoms is core to improving efficiency within breathlessness care.

Identifiers

PMID41257188
PMCPMC12621120

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.